Sign In or Subscribe

Get Full access to Top 1000 data, subscribe from only €29

Register Now »

Biomarin

Add to comparison

BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.

Financial Data

31st Dec 16 Source: CRO
- €377.3 million turnover
- €0.1 million profit
- 236 employees
- Auditor: KPMG
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
31st Dec 15 Source: CRO
- €241.5 million turnover
- €0.2 million profit
- 158 employees
- Auditor: KPMG
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
1 more year available »

Ranking

By Turnover

(€377.3 million)

185^th in Top Companies
25^th in Health

By Employees

(236)

532^nd in Top Companies
72^nd in Health

Nearest in Top 1000

Top 5 By Industry

185^th in Top Companies

By Turnover

Employees: 236
Turnover: €377.3 million

Employees

Michael O’Donnell CEO/Managing Director

Latest News

Newsletter